Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Nagpure, B V ^a   Bian, Jin Song ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CARDIOVASCULAR SYSTEM; MAMMALS; NITRIC OXIDE; SIGNALING; SULFUR DETERMINATION;

CARDIOPROTECTION; CHEMICAL INTERACTIONS; INDEPENDENT REGULATORS; PATHOPHYSIOLOGICAL; PHYSIOLOGICAL FUNCTIONS; SIGNALING MOLECULES; SIGNALING TRANSDUCTION; VASCULAR TONES;

HYDROGEN SULFIDE;

HYDROGEN SULFIDE; NITRIC OXIDE; GASOTRANSMITTER;

ANGIOGENESIS; ANIMAL CELL; BIOCHEMISTRY; BLOOD VESSEL TONE; CARDIOVASCULAR SYSTEM; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HUMAN; MAMMAL CELL; METABOLISM; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; REGULATORY MECHANISM; REVIEW; SYNTHESIS; ANIMAL; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR SYSTEM; GASOTRANSMITTERS; HUMANS; HYDROGEN SULFIDE; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 84948390431     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/6904327     Document Type: Review

References (167)

1. R. Wang, "Two's company, three's a crowd: CanH2S be the third endogenous gaseous transmitter?" The FASEB Journal, vol. 16, no. 13, pp. 1792-1798, 2002.
2. R. F. Furchgott and J. V. Zawadzki, "The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, " Nature, vol. 288, no. 5789, pp. 373-376, 1980.
3. L. J. Ignarro, G. M. Buga, K. S. Wood, R. E. Byrns, and G. Chaudhuri, "Endothelium-derived relaxing factor produced and released fromartery and vein is nitric oxide, " Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 24, pp. 9265-9269, 1987.
4. S. Moncada, R. M. J. Palmer, and E. A. Higgs, "Nitric oxide: physiology, pathophysiology, and pharmacology, " Pharmacological Reviews, vol. 43, no. 2, pp. 109-142, 1991.
5. L. R. Goodwin, D. Francom, F. P. Dieken et al. , "Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports, " Journal of Analytical Toxicology, vol. 13, no. 2, pp. 105-109, 1989.
6. L. Li, P. Rose, and P. K. Moore, "Hydrogen sulfide and cell signaling, " Annual Review of Pharmacology and Toxicology, vol. 51, no. 1, pp. 169-187, 2011.
7. M. Whiteman and P. K. Moore, "Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?" Journal of Cellular and Molecular Medicine, vol. 13, no. 3, pp. 488-507, 2009.
8. W. D. Gao, C. I. Murray, Y. Tianet al. , "Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function, " Circulation Research, vol. 111, no. 8, pp. 1002-1011, 2012.
9. Q.-C. Yong, J. L. Cheong, F. Hua et al. , "Regulation of heart function by endogenous gaseous mediators-crosstalk between nitric oxide and hydrogen sulfide, " Antioxidants and Redox Signaling, vol. 14, no. 11, pp. 2081-2091, 2011.
10. C. Szabo, "Gaseotransmitters: new frontiers for translational science, " Science Translational Medicine, vol. 2, no. 59, Article ID 59ps54, 2010.
11. L.-F. Hu, M. Lu, P. T. Hon Wong, and J.-S. Bian, "Hydrogen sulfide: neurophysiology and neuropathology, " Antioxidants and Redox Signaling, vol. 15, no. 2, pp. 405-419, 2011.
12. N. Shibuya, M. Tanaka, M. Yoshida et al. , "3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain, " Antioxidants & Redox Signaling, vol. 11, no. 4, pp. 703-714, 2009.
13. W. Guo, Z.-Y. Cheng, and Y.-Z. Zhu, "Hydrogen sulfide and translationalmedicine, " Acta Pharmacologica Sinica, vol. 34, no. 10, pp. 1284-1291, 2013.
14. K. Abe and H. Kimura, "Thepossible role of hydrogen sulfide as an endogenous neuromodulator, " Journal of Neuroscience, vol. 16, no. 3, pp. 1066-1071, 1996.
15. B. Geng, J. Yang, Y. Qi et al. , "H2S generated by heart in rat and its effects on cardiac function, " Biochemical and Biophysical Research Communications, vol. 313, no. 2, pp. 362-368, 2004.
16. W. Zhao, J. Zhang, Y. Lu, and R. Wang, "The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener, " The EMBO Journal, vol. 20, no. 21, pp. 6008-6016, 2001.
17. G. Yang, L. Wu, B. Jiang et al. , "H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase, " Science, vol. 322, no. 5901, pp. 587-590, 2008.
18. J. Bełtowski and A. Jamroz-Winiewska, "Hydrogen sulfide and endothelium-dependent vasorelaxation, " Molecules, vol. 19, no. 12, pp. 21183-21199, 2014.
19. M. Ishigami, K. Hiraki, K. Umemura, Y. Ogasawara, K. Ishii, and H. Kimura, "A source of hydrogen sulfide and a mechanism of its release in the brain, " Antioxidants and Redox Signaling, vol. 11, no. 2, pp. 205-214, 2009.
20. K. R. Olson, N. L. Whitfield, S. E. Bearden et al. , "Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 298, no. 1, pp. R51-R60, 2010.
21. O. Kabil and R. Banerjee, "Enzymology ofH2S biogenesis, decay and signaling, " Antioxidants and Redox Signaling, vol. 20, no. 5, pp. 770-782, 2014.
22. H. Kimura, "Hydrogen sulfide: its production, release and functions, " Amino Acids, vol. 41, no. 1, pp. 113-121, 2011.
23. Y. Kimura, Y.-I. Goto, and H. Kimura, "Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria, " Antioxidants & Redox Signaling, vol. 12, no. 1, pp. 1-13, 2010.
24. N. Shibuya, S. Koike, M. Tanaka et al. , "A novel pathway for the production of hydrogen sulfide fromD-cysteine in mammalian cells, " Nature Communications, vol. 4, article 1366, 2013.
25. H. Kimura, "Metabolic turnover of hydrogen sulfide, " Frontiers in Physiology, vol. 3, article 101, 2012.
26. W. K. Alderton, C. E. Cooper, and R. G. Knowles, "Nitric oxide synthases: structure, function and inhibition, " Biochemical Journal, vol. 357, no. 3, pp. 593-615, 2001.
27. H. M. Abu-Soud and D. J. Stuehr, "Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 22, pp. 10769-10772, 1993.
28. D. Stuehr, S. Pou, and G. M. Rosen, "Oxygen reduction by nitricoxide synthases, "The Journal of Biological Chemistry, vol. 276, no. 18, pp. 14533-14536, 2001.
29. R. G. Knowles, M. Palacios, R. M. J. Palmer, and S. Moncada, "Formation of nitric oxide from L-Arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase, " Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 13, pp. 5159-5162, 1989.
30. U. Frstermann, E. I. Closs, J. S. Pollock et al. , "Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions, " Hypertension, vol. 23, no. 6, part 2, pp. 1121-1131, 1994.
31. M. A. Marletta, P. S. Yoon, R. Iyengar, C. D. Leaf, and J. S. Wishnok, "Macrophage oxidation of L-Arginine to nitrite and nitrate: nitric oxide is an intermediate, " Biochemistry, vol. 27, no. 24, pp. 8706-8711, 1988.
32. Y. Yui, R. Hattori, K. Kosuga et al. , "Calmodulin-independent nitric oxide synthase fromrat polymorphonuclear neutrophils, " The Journal of Biological Chemistry, vol. 266, no. 6, pp. 3369-3371, 1991.
33. P. A. Marsden A, H. H. Q. Heng, S. W. Scherer et al. , "Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene, " The Journal of Biological Chemistry, vol. 268, no. 23, pp. 17478-17488, 1993.
34. N. S. Bryan, K. Bian, and F. Murad, "Discovery of the nitric oxide signaling pathway and targets for drug development, " Frontiers in Bioscience, vol. 14, no. 1, pp. 1-18, 2009.
35. J. O. Lundberg, E. Weitzberg, andM. T. Gladwin, "The nitratenitrite-nitric oxide pathway in physiology and therapeutics, " Nature Reviews Drug Discovery, vol. 7, no. 2, pp. 156-167, 2008.
36. J. O. Lundberg and E. Weitzberg, "NO-synthase independent NO generation in mammals, " Biochemical and Biophysical Research Communications, vol. 396, no. 1, pp. 39-45, 2010.
37. F. X. Guix, I. Uribesalgo, M. Coma, and F. J. Munoz, "The physiology and pathophysiology of nitric oxide in the brain, " Progress in Neurobiology, vol. 76, no. 2, pp. 126-152, 2005.
38. Y. Hou, Z. Guo, J. Li, and P. G. Wang, "Seleno compounds and glutathione peroxidase catalyzed decomposition of Snitrosothiols, " Biochemical and Biophysical Research Communications, vol. 228, no. 1, pp. 88-93, 1996.
39. D. Nikitovic and A. Holmgren, "S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide, " The Journal of Biological Chemistry, vol. 271, no. 32, pp. 19180-19185, 1996.
40. C. Sereglyes, A. U. Igamberdiev, A. Maassen, J. Hennig, D. Dudits, and R. D. Hill, "NO-degradation by alfalfa class 1 hemoglobin (Mhb1): a possible link to PR-1a gene expression in Mhb1-overproducing tobacco plants, " FEBS Letters, vol. 571, no. 1-3, pp. 61-66, 2004.
41. M. Whiteman, U. Ketsawatsakul, and B. Halliwell, "A reassessment of the peroxynitrite scavenging activity of uric acid, " Annals of the New York Academy of Sciences, vol. 962, pp. 242-259, 2002.
42. K. R. Olson, "A practical look at the chemistry and biology of hydrogen sulfide, " Antioxidants and Redox Signaling, vol. 17, no. 1, pp. 32-44, 2012.
43. J. M. Fukuto, S. J. Carrington, D. J. Tantillo et al. , "Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species, " Chemical Research in Toxicology, vol. 25, no. 4, pp. 769-793, 2012.
44. H. Kimura, "Production and physiological effects of hydrogen sulfide, " Antioxidants & Redox Signaling, vol. 20, no. 5, pp. 783-793, 2014.
45. A. Fago, F. B. Jensen, B. Tota et al. , "Integrating nitric oxide, nitrite and hydrogen sulfide signaling in the physiological adaptations to hypoxia: a comparative approach, " Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, vol. 162, no. 1, pp. 1-6, 2012.
46. M. Whiteman, J. S. Armstrong, S. H. Chu et al. , "The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'?" Journal of Neurochemistry, vol. 90, no. 3, pp. 765-768, 2004.
47. S. Bruce King, "Potential biological chemistry of hydrogen sulfide (H2S) with the nitrogen oxides, " Free Radical Biology and Medicine, vol. 55, pp. 1-7, 2013.
48. J. M. Fukuto, M. I. Jackson, N. Kaludercic, and N. Paolocci, "Examining nitroxyl in biological systems, " Methods in Enzymology, vol. 440, pp. 411-431, 2008.
49. Q.-C. Yong, L.-F. Hu, S. Wang, D. Huang, and J.-S. Bian, "Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl, " Cardiovascular Research, vol. 88, no. 3, pp. 482-491, 2010.
50. Y. Ge and R. L. Moss, "Nitroxyl, redox switches, cardiac myofilaments, and heart failure: a prequel to novel therapeutics?" Circulation Research, vol. 111, no. 8, pp. 954-956, 2012.
51. A. V. Zima and L. A. Blatter, "Redox regulation of cardiac calcium channels and transporters, " Cardiovascular Research, vol. 71, no. 2, pp. 310-321, 2006.
52. G. Keceli, C. D. Moore, J. W. Labonte, and J. P. Toscano, "NMR detection and study of hydrolysis of HNO-derived sulfinamides, " Biochemistry, vol. 52, no. 42, pp. 7387-7396, 2013.
53. M. R. Kumars, J. M. Fukuto, K. M. Miranda, and P. J. Farmer, "Reactions of HNO with heme proteins: new routes to HNOheme complexes and insight into physiological effects, " Inorganic Chemistry, vol. 49, no. 14, pp. 6283-6292, 2010.
54. A. Arcaro, G. Lembo, and C. G. Tocchetti, "Nitroxyl (HNO) for treatment of acute heart failure, " Current Heart Failure Reports, vol. 11, no. 3, pp. 227-235, 2014.
55. G. Kojda and K. Kottenberg, "Regulation of basal myocardial function byNO, " Cardiovascular Research, vol. 41, no. 3, pp. 514-523, 1999.
56. M. G. Vila-Petroff, A. Younes, J. Egan, E. G. Lakatta, and S. J. Sollott, "Activation of distinct cAMP-dependent and cGMPdependent pathways by nitric oxide in cardiac myocytes, " Circulation Research, vol. 84, no. 9, pp. 1020-1031, 1999.
57. S. O. Marx, S. Reiken, Y. Hisamatsu et al. , "PKA phosphorylation dissociates FKBP12. 6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts, " Cell, vol. 101, no. 4, pp. 365-376, 2000.
58. A. M. Shah, H. A. Spurgeon, S. J. Sollott, A. Talo, and E. G. Lakatta, "8-Bromo-cGMP reduces themyofilament response to Ca2+ in intact cardiac myocytes, " Circulation Research, vol. 74, no. 5, pp. 970-978, 1994.
59. E. Takimoto, H. C. Champion, D. Belardi et al. , "cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism, " Circulation Research, vol. 96, no. 1, pp. 100-109, 2005.
60. L. Xu, J. P. Eu, G. Meissner, and J. S. Stamler, "Activation of the cardiac calcium release channel (Ryanodoine receptor) by poly-S-nitrosylation, " Science, vol. 279, no. 5348, pp. 234-237, 1998.
61. B. Geng, L. Chang, C. Pan et al. , "Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol, " Biochemical and Biophysical Research Communications, vol. 318, no. 3, pp. 756-763, 2004.
62. Y.-G. Sun, Y.-X. Cao, W.-W. Wang, S.-F. Ma, T. Yao, and Y.-C. Zhu, "Hydrogen sulphide is an inhibitor of L-Type calcium channels and mechanical contraction in rat cardiomyocytes, " Cardiovascular Research, vol. 79, no. 4, pp. 632-641, 2008.
63. Q. C. Yong, T.-T. Pan, L.-F. Hu, and J.-S. Bian, "Negative regulation of beta-Adrenergic function by hydrogen sulphide in the rat hearts, " Journal ofMolecular and Cellular Cardiology, vol. 44, no. 4, pp. 701-710, 2008.
64. Y.-H. Liu, M. Lu, L.-F. Hu, P. T.-H. Wong, G. D. Webb, and J.-S. Bian, "Hydrogen sulfide in the mammalian cardiovascular system, " Antioxidants and Redox Signaling, vol. 17, no. 1, pp. 141-185, 2012.
65. M. W. Warenycia, J. A. Steele, E. Karpinski, andR. J. Reiffenstein, "Hydrogen sulfide in combination with taurine or cysteic acid reversibly abolishes sodium currents in neuroblastoma cells, " NeuroToxicology, vol. 10, no. 2, pp. 191-199, 1989.
66. C. Szabõ, "Hydrogen sulphide and its therapeutic potential, " Nature Reviews Drug Discovery, vol. 6, no. 11, pp. 917-935, 2007.
67. J. L. Miljkovic, I. Kenkel, I. Ivanovi-Burmazovi, and M. R. Filipovic, "Generation of HNO and HSNO from nitrite by heme-iron-catalyzed metabolism with H2S, " Angewandte Chemie, vol. 52, no. 46, pp. 12061-12064, 2013.
68. S. L. Quiroga, A. E. Almaraz, V. T. Amorebieta, L. L. Perissinotti, and J. A. Olabe, "Addition and redox reactivity of hydrogen sulfides (H2S/HS-) with nitroprusside: new chemistry of nitrososulfide ligands, " Chemistry, vol. 17, no. 15, pp. 4145-4156, 2011.
69. M. R. Filipovic and I. Ivanovic-Burmazovic, "The kinetics and character of the intermediates formed in the reaction between sodium nitroprusside and hydrogen sulfide need further clarification, " Chemistry-A European Journal, vol. 18, no. 42, pp. 13538-13540, 2012.
70. N. Paolocci, T. Katori, H. C. Champion et al. , "Positive inotropic and lusitropic effects of HNO/NO-in failing hearts: Independence from-Adrenergic signaling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 9, pp. 5537-5542, 2003.
71. N. Paolocci, W. F. Saavedra, K. M. Miranda et al. , "Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10463-10468, 2001.
72. C. G. Tocchetti, W. Wang, J. P. Froehlich et al. , "Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulumCa2+ cycling, " Circulation Research, vol. 100, no. 1, pp. 96-104, 2007.
73. V. Sivakumaran, B. A. Stanley, C. G. Tocchetti et al. , "HNO Enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization, " Antioxidants and Redox Signaling, vol. 19, no. 11, pp. 1185-1197, 2013.
74. T. Katori, D. B. Hoover, J. L. Ardell et al. , "Calcitonin generelated peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure, " Circulation Research, vol. 96, no. 2, pp. 234-243, 2005.
75. C. G. Tocchetti, B. A. Stanley, C. I. Murray et al. , "Playing with cardiac 'redox switches': the 'HNO way' to modulate cardiac function, " Antioxidants & Redox Signaling, vol. 14, no. 9, pp. 1687-1698, 2011.
76. J. K. Wachira and T. P. Stys, "Cardiovascular disease and bridging the diagnostic gap, " South Dakota Medicine, vol. 66, no. 9, pp. 366-369, 2013.
77. S. P. Jones, W. G. Girod, A. J. Palazzo et al. , "Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 276, no. 5, pp. H1567-H1573, 1999.
78. S. P. Jones, J. J. M. Greer, R. Van Haperen, D. J. Duncker, R. De Crom, and D. J. Lefer, "Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 8, pp. 4891-4896, 2003.
79. S. Janssens, P. Pokreisz, L. Schoonjans et al. , "Cardiomyocytespecific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction, " Circulation Research, vol. 94, no. 9, pp. 1256-1262, 2004.
80. B. W. Roberts, J. Mitchell, J. H. Kilgannon, M. E. Chansky, and S. Trzeciak, "Nitric oxide donor agents for the treatment of ischemia/reperfusion injury in human subjects: a systematic review, " Shock, vol. 39, no. 3, pp. 229-239, 2013.
81. T. Mizuno, M. Watanabe, T. Sakamoto, and M. Sunamori, "L-Arginine, a nitric oxide precursor, attenuates ischemiareperfusion injury by inhibiting inositol-1, 4, 5-Triphosphate, " Journal of Thoracic and Cardiovascular Surgery, vol. 115, no. 4, pp. 931-936, 1998.
82. A. Beresewicz, E. Karwatowska-Prokopczuk, B. Lewartowski, and K. Cedro-Ceremuzynska, "A protective role of nitric oxide in isolated ischaemic/reperfused rat heart, " Cardiovascular Research, vol. 30, no. 6, pp. 1001-1008, 1995.
83. R. Schulz, M. Kelm, and G. Heusch, "Nitric oxide inmyocardial ischemia/reperfusion injury, " Cardiovascular Research, vol. 61, no. 3, pp. 402-413, 2004.
84. Z. Xu, X. Ji, and P. G. Boysen, "Exogenous nitric oxide generates ROS and induces cardioprotection: Involvement of PKG, mitochondrial KATP channels, and ERK, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 286, no. 4, pp. H1433-H1440, 2004.
85. D.-M. Zhang, Y. Chai, J. R. Erickson, J. H. Brown, D. M. Bers, and Y.-F. Lin, "Modulation of sarcolemmal ATP-sensitive potassiumchannels by nitric oxide via sGC/PKG/ROS/ERK1/2/CaMKII signaling in ventricular cardiomyocytes, " The Journal of Physiology, vol. 592, part 5, pp. 971-990, 2014.
86. A. Calderone, C. M. Thaik, N. Takahashi, D. L. F. Chang, andW. S. Colucci, "Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts, " Journal of Clinical Investigation, vol. 101, no. 4, pp. 812-818, 1998.
87. Y. Z. Zhu, Z. Wang, P. Ho et al. , "Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats, " Journal of Applied Physiology, vol. 102, no. 1, pp. 261-268, 1985.
88. Z. Zhang, H. Huang, P. Liu, C. Tang, and J. Wang, "Hydrogen sulfide contributes to cardioprotection during ischemiareperfusion injury by opening KATP channels, " Canadian Journal of Physiology and Pharmacology, vol. 85, no. 12, pp. 1248-1253, 2007.
89. R. M. Osipov, M. P. Robich, J. Feng et al. , "Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection, " Journal of Cardiovascular Pharmacology, vol. 54, no. 4, pp. 287-297, 2009.
90. X. Wang, Q. Wang, W. Guo, and Y. Z. Zhu, "Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection, " Bioscience Reports, vol. 31, no. 2, pp. 87-98, 2011.
91. S. Jha, J. W. Calvert, M. R. Duranski, A. Ramachandran, and D. J. Lefer, "Hydrogen sulfide attenuates hepatic ischemiareperfusion injury: Role of antioxidant and antiapoptotic signaling, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 295, no. 2, pp. H801-H806, 2008.
92. C. E. Cooper andG. C. Brown, "Theinhibition of mitochondrial cytochrome oxidase by the gases carbonmonoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance, " Journal of Bioenergetics and Biomembranes, vol. 40, no. 5, pp. 533-539, 2008.
93. Q. C. Yong, S. W. Lee, C. S. Foo, K. L. Neo, X. Chen, and J.-S. Bian, "Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 295, no. 3, pp. H1330-H1340, 2008.
94. J.-S. Bian, C. Y. Qian, T.-T. Pan et al. , "Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes, " Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 2, pp. 670-678, 2006.
95. T.-T. Pan, Y. Q. Chen, and J.-S. Bian, "All in the timing: a comparison between the cardioprotection induced by H2S preconditioning and post-infarction treatment, " European Journal of Pharmacology, vol. 616, no. 1-3, pp. 160-165, 2009.
96. T.-T. Pan, K. L. Neo, L.-F. Hu, Q. C. Yong, and J.-S. Bian, "H2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes, " The American Journal of Physiology-Cell Physiology, vol. 294, no. 1, pp. C169-C177, 2008.
97. T.-T. Pan, Z.-N. Feng, S. W. Lee, P. K. Moore, and J.-S. Bian, "Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes, " Journal of Molecular and Cellular Cardiology, vol. 40, no. 1, pp. 119-130, 2006.
98. B. Sojitra, Y. Bulani, U. K. Putcha et al. , "Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice, "Molecular and Cellular Biochemistry, vol. 360, no. 1-2, pp. 61-69, 2012.
99. Z. Altaany, G. Yang, and R. Wang, "Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells, " Journal of Cellular and Molecular Medicine, vol. 17, no. 7, pp. 879-888, 2013.
100. A. L. King, D. J. Polhemus, S. Bhushan et al. , "Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthasenitric oxide dependent, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 8, pp. 3182-3187, 2014.
101. S. Kubo, I. Doe, Y. Kurokawa, H. Nishikawa, and A. Kawabata, "Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension, " Toxicology, vol. 232, no. 1-2, pp. 138-146, 2007.
102. B. Geng, Y. Cui, J. Zhao et al. , "Hydrogen sulfide downregulates the aortic L-Arginine/nitric oxide pathway in rats, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 293, no. 4, pp. R1608-R1618, 2007.
103. G. Szalay, M. Sauter, J. Hald, A. Weinzierl, R. Kandolf, and K. Klingel, "Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders, " The American Journal of Pathology, vol. 169, no. 6, pp. 2085-2093, 2006.
104. P. Mukhopadhyay, M. Rajesh, S. Btkai et al. , "Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro, "TheAmerican Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 5, pp. H1466-H1483, 2009.
105. W. Hua, Q. Chen, F. Gong, C. Xie, S. Zhou, and L. Gao, "Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-inducedmyocarditis, " Life Sciences, vol. 93, no. 24, pp. 949-954, 2013.
106. W. Zhao, J. F. Ndisang, and R. Wang, "Modulation of endogenous production of H2S in rat tissues, " Canadian Journal of Physiology and Pharmacology, vol. 81, no. 9, pp. 848-853, 2003.
107. K. M. Miranda, T. Katori, C. L. Torres De Holding et al. , "Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo, " Journal of Medicinal Chemistry, vol. 48, no. 26, pp. 8220-8228, 2005.
108. B. B. Queliconi, A. P. Wojtovich, S. M. Nadtochiy, A. J. Kowaltowski, and P. S. Brookes, "Redox regulation of the mitochondrial KATP channel in cardioprotection, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1813, no. 7, pp. 1309-1315, 2011.
109. B. E. Vanuffelen, J. van der Zee, B. M. de Koster, J. Vansteveninck, and J. G. R. Elferink, "Intracellular but not extracellular conversion of nitroxyl anion into nitric oxide leads to stimulation of human neutrophil migration, " Biochemical Journal, vol. 330, part 2, pp. 719-722, 1998.
110. H. Hayakawa, Y. Hirata, M. Kakoki et al. , "Role of nitric oxidecGMP pathway in adrenomedullin-induced vasodilation in the rat, " Hypertension, vol. 33, no. 2, pp. 689-693, 1999.
111. D. K. Mistry and C. J. Garland, "Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BKCa) in smooth muscle cells isolated fromthe ratmesenteric artery, " British Journal of Pharmacology, vol. 124, no. 6, pp. 1131-1140, 1998.
112. M. Alonso-Galicia, A. G. Hudetz, H. Shen, D. R. Harder, and R. J. Roman, "Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation, " Stroke, vol. 30, no. 12, pp. 2727-2734, 1999.
113. B. P. Luchsinger, E. N. Rich, A. J. Gow, E. M. Williams, J. S. Stamler, and D. J. Singel, "Routes to S-nitroso-hemoglobin formation with heme redox and preferential reactivity in the subunits, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 461-466, 2003.
114. B. W. Allen, J. S. Stamler, and C. A. Piantadosi, "Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation, " Trends inMolecularMedicine, vol. 15, no. 10, pp. 452-460, 2009.
115. R. Wang, "Physiological implications of hydrogen sulfide: a whiff exploration that blossomed, " Physiological Reviews, vol. 92, no. 2, pp. 791-896, 2012.
116. W. Zhao and R. Wang, "H2S-induced vasorelaxation and underlying cellular and molecular mechanisms, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 283, no. 2, pp. H474-H480, 2002.
117. S. W. Lee, Y. Cheng, P. Moore, and J. S. Bian, "Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells, " Biochemical and Biophysical Research Communications, vol. 358, no. 4, pp. 1142-1147, 2007.
118. L. Kiss, E. A. Deitch, andC. Szab, "Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition, " Life Sciences, vol. 83, no. 17-18, pp. 589-594, 2008.
119. M. Y. Ali, C. Y. Ping, Y.-Y. P. Mok et al. , "Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?" British Journal of Pharmacology, vol. 149, no. 6, pp. 625-634, 2006.
120. R. Hosoki, N. Matsuki, and H. Kimura, "The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide, " Biochemical and Biophysical Research Communications, vol. 237, no. 3, pp. 527-531, 1997.
121. Y.-H. Liu and J.-S. Bian, "Bicarbonate-dependent effect of hydrogen sulfide on vascular contractility in rat aortic rings, " American Journal of Physiology: Cell Physiology, vol. 299, no. 4, pp. C866-C872, 2010.
122. K.-T. Huang, C.-C. Yin, J.-H. Wu, and H.-H. Huang, "Superoxide determines nitric oxide uptake rate by vascular smooth muscle cells, " FEBS Letters, vol. 579, no. 20, pp. 4349-4354, 2005.
123. A. Berenyiova, M. Grman, A. Mijuskovic et al. , "The reaction products of sulfide and S-nitrosoglutathione are potent vasorelaxants, " Nitric Oxide, vol. 46, pp. 123-130, 2015.
124. K. L. Andrews, J. C. Irvine, M. Tare et al. , "A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries, " British Journal of Pharmacology, vol. 157, no. 4, pp. 540-550, 2009.
125. K. M. Rusche, M. M. Spiering, and M. A. Marletta, "Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase, " Biochemistry, vol. 37, no. 44, pp. 15503-15512, 1998.
126. S. Adak, Q. Wang, and D. J. Stuehr, "Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase: implications for mechanism, " Journal of Biological Chemistry, vol. 275, no. 43, pp. 33554-33561, 2000.
127. J. C. Wanstall, T. K. Jeffery, A. Gambino, F. Lovren, and C. R. Triggle, "Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion, " British Journal of Pharmacology, vol. 134, no. 3, pp. 463-472, 2001.
128. J. C. Irvine, J. L. Favaloro, and B. K. Kemp-Harper, "NOactivates soluble guanylate cyclase andKv channels to vasodilate resistance arteries, " Hypertension, vol. 41, no. 6, pp. 1301-1307, 2003.
129. K. L. Andrews, N. G. Lumsden, J. Farry et al. , "Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance, " Clinical Science (London), vol. 129, no. 2, pp. 179-187, 2015.
130. M. Dux, C. Will, B. Vogler, M. R. Filipovic, and K. Messlinger, "Meningeal blood flow is controlled by H2S-NO crosstalk activating HNO-TRPA1-CGRP signalling, " British Journal of Pharmacology, 2015.
131. W. Yanfei, S. Lin, D. Junbao, and T. Chaoshu, "Impact of larginine on hydrogen sulfide/cystathionine-lyase pathway in rats with high blood flow-induced pulmonary hypertension, " Biochemical and Biophysical Research Communications, vol. 345, no. 2, pp. 851-857, 2006.
132. C. Coletta, A. Papapetropoulos, K. Erdelyi et al. , "Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 23, pp. 9161-9166, 2012.
133. M. Eberhardt, M. Dux, B. Namer et al. , "H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway, " Nature Communications, vol. 5, article 4381, 2014.
134. Q. Huang, A. Sparatore, P. del Soldato, L. Wu, and K. Desai, "Hydrogen sulfide releasing aspirin, ACS14, attenuates high glucose-induced increased methylglyoxal and oxidative stress in cultured vascular smoothmuscle cells, " PLoS ONE, vol. 9, no. 6, Article ID e97315, 2014.
135. L. Munaron, "Intracellular calcium, endothelial cells and angiogenesis, " Recent Patents on Anti-Cancer Drug Discovery, vol. 1, no. 1, pp. 105-119, 2006.
136. C. Fischer, M. Schneider, and P. Carmeliet, "Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis, " Handbook of Experimental Pharmacology, vol. 176, no. 2, pp. 157-212, 2006.
137. M. Ziche and L. Morbidelli, "Nitric oxide and angiogenesis, " Journal of Neuro-Oncology, vol. 50, no. 1-2, pp. 139-148, 2000.
138. L. Munaron and A. Fiorio Pla, "Endothelial calcium machinery and angiogenesis: understanding physiology to interfere with pathology, " Current Medicinal Chemistry, vol. 16, no. 35, pp. 4691-4703, 2009.
139. W.-J. Cai, M.-J. Wang, P. K. Moore, H.-M. Jin, T. Yao, and Y.-C. Zhu, "The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation, " Cardiovascular Research, vol. 76, no. 1, pp. 29-40, 2007.
140. A. Papapetropoulos, A. Pyriochou, Z. Altaany et al. , "Hydrogen sulfide is an endogenous stimulator of angiogenesis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 51, pp. 21972-21977, 2009.
141. M. Bucci, A. Papapetropoulos, V. Vellecco et al. , "Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 10, pp. 1998-2004, 2010.
142. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A. M. Zeiher, "Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, " Nature, vol. 399, no. 6736, pp. 601-605, 1999.
143. N. D. Tsihlis, J. Murar, M. R. Kapadia et al. , "Isopropylamine NONOate (IPA/NO)moderates neointimal hyperplasia following vascular injury, " Journal ofVascular Surgery, vol. 51, no. 5, pp. 1248-1259, 2010.
144. A. J. Norris, M. R. Sartippour, M. Lu et al. , "Nitroxyl inhibits breast tumor growth and angiogenesis, " International Journal of Cancer, vol. 122, no. 8, pp. 1905-1910, 2008.
145. M. Matsuda and I. Shimomura, "Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer, " Obesity Research & Clinical Practice, vol. 7, no. 5, pp. e330-e341, 2013.
146. D. G. Harrison and M. C. Gongora, "Oxidative stress and hypertension, " Medical Clinics of North America, vol. 93, no. 3, pp. 621-635, 2009.
147. D.-F. Dai and P. S. Rabinovitch, "Cardiac aging in mice and humans: the role of mitochondrial oxidative stress, " Trends in Cardiovascular Medicine, vol. 19, no. 7, pp. 213-220, 2009.
148. S. Selemidis, G. J. Dusting, H. Peshavariya, B. K. Kemp-Harper, and G. R. Drummond, "Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells, " Cardiovascular Research, vol. 75, no. 2, pp. 349-358, 2007.
149. B. E. Lopez, M. Shinyashiki, T. H. Han, and J. M. Fukuto, "Antioxidant actions of nitroxyl (HNO), " Free Radical Biology and Medicine, vol. 42, no. 4, pp. 482-491, 2007.
150. R. N. Dixon, "The heats of formation ofHNOand of DNO, " The Journal of Chemical Physics, vol. 104, no. 17, pp. 6905-6906, 1996.
151. D. A. Wink, K. M. Miranda, M. G. Espey et al. , "Mechanisms of the antioxidant effects of nitric oxide, " Antioxidants and Redox Signaling, vol. 3, no. 2, pp. 203-213, 2001.
152. E. Q. Lin, J. C. Irvine, A. H. Cao et al. , "Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation, " PLoS ONE, vol. 7, no. 4, Article ID e34892, 2012.
153. A. A. Miller, K. F. Maxwell, S. Chrissobolis et al. , "Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity, " Free Radical Biology and Medicine, vol. 60, pp. 264-271, 2013.
154. M. Whiteman, L. Li, I. Kostetski et al. , "Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide, " Biochemical and Biophysical Research Communications, vol. 343, no. 1, pp. 303-310, 2006.
155. S. A. Surez, D. E. Bikiel, D. E. Wetzler, M. A. Marti"Time-resolved electrochemical quantification of azanone (HNO) at low nanomolar level, " Analytical Chemistry, vol. 85, no. 21, pp. 10262-10269, 2013.
156. S. Donzelli, M. G. Espey, D. D. Thomas et al. , "Discriminating formation of HNO from other reactive nitrogen oxide species, " Free Radical Biology andMedicine, vol. 40, no. 6, pp. 1056-1066, 2006.
157. M. R. Cline, C. Tu, D. N. Silverman, and J. P. Toscano, "Detection of nitroxyl (HNO) by membrane inlet mass spectrometry, " Free Radical Biology andMedicine, vol. 50, no. 10, pp. 1274-1279, 2011.
158. A. T. Wrobel, T. C. Johnstone, A. Deliz Liang, S. J. Lippard, and P. Rivera-Fuentes, "Afast and selective near-infrared fluorescent sensor for multicolor imaging of biological nitroxyl (HNO), " Journal of the American Chemical Society, vol. 136, no. 12, pp. 4697-4705, 2014.
159. G.-J. Mao, X.-B. Zhang, X.-L. Shi et al. , "A highly sensitive and reductant-resistant fluorescent probe for nitroxyl in aqueous solution and serum, " Chemical Communications, vol. 50, no. 43, pp. 5790-5792, 2014.
160. X. Jing, F. Yu, and L. Chen, "Visualization of nitroxyl (HNO) in vivo via a lysosome-Targetable near-infrared fluorescent probe, " Chemical Communications, vol. 50, no. 91, pp. 14253-14256, 2014.
161. M. Saleem and H. Ohshima, "Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme, " Biochemical and Biophysical Research Communications, vol. 315, no. 2, pp. 455-462, 2004.
162. P. S. Wong, J. Hyun, J. M. Fukuto et al. , "Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry, " Biochemistry, vol. 37, no. 16, pp. 5362-5371, 1998.
163. N. Paolocci, T. Katori, H. C. Champion et al. , "Positive inotropic and lusitropic effects of HNO/NO-in failing hearts: independence from-Adrenergic signaling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 9, pp. 5537-5542, 2003.
164. L. T. Cooper Jr. , "Myocarditis, " The New England Journal of Medicine, vol. 360, no. 15, pp. 1526-1538, 2009.
165. J. M. Fukuto and S. J. Carrington, "HNO signaling mechanisms, " Antioxidants and Redox Signaling, vol. 14, no. 9, pp. 1649-1657, 2011.
166. H. N. Sabbah, C. G. Tocchetti, M. Wang et al. , "Nitroxyl (HNO): a novel approach for the acute treatment of heart failure, " Circulation: Heart Failure, vol. 6, no. 6, pp. 1250-1258, 2013.
167. A. R. Butler and C. Glidewell, "Recent chemical studies of sodium nitroprusside relevant to its hypotensive action, " Chemical Society Reviews, vol. 16, pp. 361-380, 1987.